Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Index by author

01 December 2018; volume 52, issue 6

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abubakar, Ibrahim

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  2. Agusti, Alvar

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
  3. Al-Dabbagh, Yusuf

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 17 Aug. 2022.
  4. Anderson, Sarah R.

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  5. Antoni, Christian

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  6. Ariel, Amnon

    1. Suissa, Samy, and Amnon Ariel. "Triple therapy trials in COPD: a precision medicine opportunity." European Respiratory Journal 52.6 (2018): 1801848. Web. 17 Aug. 2022.
  7. Atieh, Eyad

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.

B

  1. Bachert, Claus

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 17 Aug. 2022.
  2. Bajwah, Sabrina

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.
  3. Baldwin, David R.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  4. Bantubani, Nonkqubela

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  5. Barber, Clair

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  6. Barco, Stefano

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  7. Bartlett, Emily C.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  8. Beasley, Richard

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 17 Aug. 2022.
  9. Beckett, Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  10. Bejuit, Raphael

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  11. Berghmans, Thierry

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  12. Besnard, Valérie

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.
  13. Bhalla, Sanjeev

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  14. Blum, Torsten Gerriet

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  15. Boucher, Richard C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  16. Boyd, Jeanette

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  17. Boyles, Susan E.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.
  18. Bradding, Peter

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  19. Brightling, Chris E.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  20. Brillet, Pierre-Yves

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.
  21. Brown, Thomas

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  22. Button, Brian

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.

C

  1. Calandriello, Lucio

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  2. Calzetta, Luigino

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 17 Aug. 2022.
  3. Cao, Xuefang

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  4. Cazzola, Mario

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 17 Aug. 2022.
  5. Celli, Bartolome

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
  6. Chalmers, James D.

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 17 Aug. 2022.
  7. Chauhan, Anoop

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  8. Chen, Xiaoyou

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  9. Chen, Yu

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  10. Cholon, Deborah M.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.
  11. Chotoo, Sunitha

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  12. Christy, Matthew

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  13. Collin, Simon M.

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  14. Conradie, Francesca

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  15. Cosio, Borja G.

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 17 Aug. 2022.
  16. Cottin, Vincent

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 17 Aug. 2022.
  17. Cramer-van der Welle, Christine M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  18. Crestani, Bruno

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  19. Cui, Wei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  20. Cunningham, Steve

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 17 Aug. 2022.
  21. Currow, David C.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.

D

  1. Dale, Katie Dorothy

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 17 Aug. 2022.
  2. Dartevelle, Philippe

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  3. Davies, Joanna M.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.
  4. Delcroix, Marion

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  5. Denholm, Justin Timothy

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 17 Aug. 2022.
  6. de Ruysscher, Dirk K.M.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  7. Desai, Sujal R.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  8. Devaraj, Anand

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  9. de Vries, Gerard

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  10. Dodd, Pete J.

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 17 Aug. 2022.

E

  1. Ekström, Magnus

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.
  2. Elliott, Scott

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  3. Enwerem, Martin

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  4. Esperet, Corinne

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.

F

  1. Fabbri, Leonardo

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  2. Fabbri, Leonardo M.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
  3. Fadel, Elie

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  4. Faivre-Finn, Corinne

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  5. Feng, Boxuan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  6. Ferreira, Hannetjie

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  7. Fontana, Nicholas C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  8. Forest, M. Gregory

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  9. Franssen, Frits M.E.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.

G

  1. Galateau-Salle, Françoise

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  2. Gamarra, Fernando

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  3. Gao, Lei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  4. Garbarine, Ian C.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  5. Gentzsch, Martina

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.
  6. Gilbert, Carlee

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 17 Aug. 2022.
  7. Giraudier, Stéphane

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.
  8. Goo, Jin Mo

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  9. Gove, Kerry

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  10. Green, Ruth H.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  11. Grigoriu, Bogdan

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  12. Groen, Harry J.M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  13. Guan, Ling

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  14. Guan, Xueling

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  15. Guasconi, Alessandro

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.

H

  1. Habibpour, Mehdi

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  2. Haldar, Pranabashis

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  3. Hansen, Niels-Christian G.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  4. Hantos, Zoltán

    1. Sly, Peter D., and Zoltán Hantos. "The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801867. Web. 17 Aug. 2022.
  5. Hardavella, Georgia

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
    2. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  6. Hargadon, Beverley

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  7. Heaney, Liam G.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  8. Hill, David B.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  9. Holtappels, Gabriele

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 17 Aug. 2022.
  10. Houben, Rein M.G.J.

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 17 Aug. 2022.
  11. Howarth, Peter

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  12. Hughes, Jennifer

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.

I

  1. Ismail, Nazir

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.

J

  1. Jakobsen, Erik

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  2. Jenkins, David

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  3. Jin, Qi

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  4. Jones, Thomas

    1. Brown, Thomas et al "Randomised controlled trials in severe asthma: selection by phenotype or stereotype." European Respiratory Journal 52.6 (2018): 1801444. Web. 17 Aug. 2022.
  5. Jovanovic, Dragana

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.

K

  1. Kartoun, Uri

    1. Kartoun, Uri. "Improving the management of spontaneous pneumothorax." European Respiratory Journal 52.6 (2018): 1801857. Web. 17 Aug. 2022.
  2. Kearns, Ciléin

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 17 Aug. 2022.
  3. Kim, Nick H.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  4. Kissner, William J.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  5. Klein, Jeffrey S.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  6. Klok, Frederikus A.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  7. Klungel, Olaf H.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  8. Konsoulova, Assia

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  9. Konstantinides, Stavros V.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  10. Kool, Mirjam

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 17 Aug. 2022.
  11. Koulouris, Nikolaos G.

    1. Spinou, Arietta, and Nikolaos G. Koulouris. "Current clinical management of smoke inhalation injuries: a reality check." European Respiratory Journal 52.6 (2018): 1802163. Web. 17 Aug. 2022.

L

  1. Lang, Irene M.

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  2. Leclercq, Georges

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 17 Aug. 2022.
  3. Leung, Janice M.

    1. Leung, Janice M., and Don D. Sin. "Inhaled corticosteroids in COPD: the final verdict is…." European Respiratory Journal 52.6 (2018): 1801940. Web. 17 Aug. 2022.
  4. Li, Hengjing

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  5. Li, Xiangwei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  6. Lindell, Kathleen

    1. Lindell, Kathleen, and Ganesh Raghu. "Palliative care for patients with pulmonary fibrosis: symptom relief is essential." European Respiratory Journal 52.6 (2018): 1802086. Web. 17 Aug. 2022.
  7. Liu, Jianmin

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  8. Liu, Zisen

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  9. Long, Robert F.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  10. Lönnroth, Knut

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.

M

  1. Ma, Yu

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  2. Maartens, Gary

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  3. MacMahon, Heber

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  4. Madani, Michael

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  5. Markovetz, Matthew R.

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  6. Martino, Mary E.B.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.
  7. Massard, Gilbert

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  8. Master, Iqbal

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  9. Matera, Maria Gabriella

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 17 Aug. 2022.
  10. Matsubara, Hiromi

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  11. Mayer, Eckhard

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  12. McPhelim, John

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  13. Meert, Anne-Pascale

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  14. Meintjes, Graeme

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  15. Menzies, Dick

    1. Menzies, Dick, and Anete Trajman. "New short regimens for latent tuberculosis treatment: safety first!." European Respiratory Journal 52.6 (2018): 1802180. Web. 17 Aug. 2022.
  16. Migliori, Giovanni Battista

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  17. Milroy, Robert

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  18. Mohr, Erika

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  19. Morales, Daniel R.

    1. Morales, Daniel R.. "Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care." European Respiratory Journal 52.6 (2018): 1801986. Web. 17 Aug. 2022.
  20. Mutti, Luciano

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.

N

  1. Nair, Arjun

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  2. Navani, Neal

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  3. Ndjeka, Norbert

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  4. Nunes, Hilario

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.

O

  1. Oluyase, Adejoke O.

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.

P

  1. Padanilam, Xavier

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  2. Paesmans, Marianne

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  3. Pan, Shouguo

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  4. Papi, Alberto

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  5. Pavord, Ian D.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  6. Peake, Michael D.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  7. Pepke-Zaba, Joanna

    1. Klok, Frederikus A. et al "Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry." European Respiratory Journal 52.6 (2018): 1801687. Web. 17 Aug. 2022.
  8. Peters, Bas J.M.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  9. Petruzzelli, Stefano

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  10. Polverino, Francesca

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 17 Aug. 2022.
  11. Porcel, José M.

    1. Porcel, José M.. "Improving the management of spontaneous pneumothorax." European Respiratory Journal 52.6 (2018): 1801918. Web. 17 Aug. 2022.
  12. Putora, Paul Martin

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.

Q

  1. Quinney, Nancy L.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.

R

  1. Rabe, Klaus F.

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
  2. Raghu, Ganesh

    1. Lindell, Kathleen, and Ganesh Raghu. "Palliative care for patients with pulmonary fibrosis: symptom relief is essential." European Respiratory Journal 52.6 (2018): 1802086. Web. 17 Aug. 2022.
    2. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  3. Ribeiro, Carla M.P.

    1. Gentzsch, Martina et al "The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model." European Respiratory Journal 52.6 (2018): 1801133. Web. 17 Aug. 2022.
  4. Rich, Anna L.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  5. Richeldi, Luca

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  6. Rogliani, Paola

    1. Cazzola, Mario et al "Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis." European Respiratory Journal 52.6 (2018): 1801586. Web. 17 Aug. 2022.
  7. Romero, Rodolfo

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  8. Rotenberg, Cécile

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.
  9. Rubin, Bruce K.

    1. Rubin, Bruce K., and David J. Thornton. "Dropping acid: why is cystic fibrosis mucus abnormal?." European Respiratory Journal 52.6 (2018): 1802057. Web. 17 Aug. 2022.

S

  1. Schaefer-Prokop, C.M.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  2. Scherpereel, Arnaud

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  3. Schnippel, Kathryn

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  4. Schramel, Franz M.N.H.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  5. Schwerk, Nico

    1. Cunningham, Steve, Carlee Gilbert, and Nico Schwerk. "The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801855. Web. 17 Aug. 2022.
  6. Sculier, Jean-Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  7. Scuri, Mario

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  8. Seo, Joon-Beom

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  9. Shen, Fei

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  10. Shrimanker, Rahul

    1. Shrimanker, Rahul, Richard Beasley, and Ciléin Kearns. "Letting the right one in: evaluating the generalisability of clinical trials." European Respiratory Journal 52.6 (2018): 1802218. Web. 17 Aug. 2022.
    2. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  11. Sin, Don D.

    1. Leung, Janice M., and Don D. Sin. "Inhaled corticosteroids in COPD: the final verdict is…." European Respiratory Journal 52.6 (2018): 1801940. Web. 17 Aug. 2022.
  12. Singh, Dave

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  13. Singh, Nalini

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  14. Sly, Peter D.

    1. Sly, Peter D., and Zoltán Hantos. "The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration." European Respiratory Journal 52.6 (2018): 1801867. Web. 17 Aug. 2022.
  15. Smith, Alexandria

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 17 Aug. 2022.
  16. Soriano, Joan B.

    1. Soriano, Joan B., Francesca Polverino, and Borja G. Cosio. "What is early COPD and why is it important?." European Respiratory Journal 52.6 (2018): 1801448. Web. 17 Aug. 2022.
    2. Soriano, Joan B.. "Challenges in interpreting trends in testing for α1-antitrypsin deficiency in COPD patients from UK primary care." European Respiratory Journal 52.6 (2018): 1802064. Web. 17 Aug. 2022.
  17. Soubrane, Christina

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.
  18. Spinou, Arietta

    1. Spinou, Arietta, and Nikolaos G. Koulouris. "Current clinical management of smoke inhalation injuries: a reality check." European Respiratory Journal 52.6 (2018): 1802163. Web. 17 Aug. 2022.
  19. Subotic, Dragan R.

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  20. Suissa, Samy

    1. Suissa, Samy, and Amnon Ariel. "Triple therapy trials in COPD: a precision medicine opportunity." European Respiratory Journal 52.6 (2018): 1801848. Web. 17 Aug. 2022.
  21. Suntila, Nelli S.M.

    1. Suntila, Nelli S.M. et al "A systematic review of clinical trial registration in major respiratory journals 2010–2018." European Respiratory Journal 52.6 (2018): 1801491. Web. 17 Aug. 2022.
  22. Sverzellati, Nicola

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.

T

  1. Tanash, Hanan

    1. Bajwah, Sabrina et al "Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study." European Respiratory Journal 52.6 (2018): 1801278. Web. 17 Aug. 2022.
  2. Tarran, Robert

    1. Hill, David B. et al "Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH." European Respiratory Journal 52.6 (2018): 1801297. Web. 17 Aug. 2022.
  3. Taveirne, Sylvie

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 17 Aug. 2022.
  4. te Riele, Julian

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  5. Thornton, David J.

    1. Rubin, Bruce K., and David J. Thornton. "Dropping acid: why is cystic fibrosis mucus abnormal?." European Respiratory Journal 52.6 (2018): 1802057. Web. 17 Aug. 2022.
  6. Trajman, Anete

    1. Menzies, Dick, and Anete Trajman. "New short regimens for latent tuberculosis treatment: safety first!." European Respiratory Journal 52.6 (2018): 1802180. Web. 17 Aug. 2022.
  7. Trauer, James McCracken

    1. Dale, Katie Dorothy et al "Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia." European Respiratory Journal 52.6 (2018): 1801218. Web. 17 Aug. 2022.

V

  1. Valeyre, Dominique

    1. Rotenberg, Cécile et al "Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia." European Respiratory Journal 52.6 (2018): 1801482. Web. 17 Aug. 2022.
  2. Van Crombruggen, Koen

    1. Van Crombruggen, Koen et al "Innate lymphoid cells in the upper airways: importance of CD117 and IL-1RI expression." European Respiratory Journal 52.6 (2018): 1800742. Web. 17 Aug. 2022.
  3. van de Garde, Ewoudt M.W.

    1. Cramer-van der Welle, Christine M. et al "Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer." European Respiratory Journal 52.6 (2018): 1801100. Web. 17 Aug. 2022.
  4. Van Schil, Paul

    1. Rich, Anna L. et al "ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe." European Respiratory Journal 52.6 (2018): 1800610. Web. 17 Aug. 2022.
  5. Variava, Ebrahim

    1. Ndjeka, Norbert et al "High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen." European Respiratory Journal 52.6 (2018): 1801528. Web. 17 Aug. 2022.
  6. Vestbo, Jørgen

    1. Agusti, Alvar et al "Inhaled corticosteroids in COPD: friend or foe?." European Respiratory Journal 52.6 (2018): 1801219. Web. 17 Aug. 2022.
    2. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.
  7. Vezzoli, Stefano

    1. Vestbo, Jørgen et al "Inhaled corticosteroid containing combinations and mortality in COPD." European Respiratory Journal 52.6 (2018): 1801230. Web. 17 Aug. 2022.

W

  1. Walsh, Simon L.F.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  2. Wang, Dakuan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  3. Wardlaw, Andrew J.

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.
  4. Wells, Athol U.

    1. Nair, Arjun et al "Variable radiological lung nodule evaluation leads to divergent management recommendations." European Respiratory Journal 52.6 (2018): 1801359. Web. 17 Aug. 2022.
  5. Wijsenbeek, Marlies S.

    1. Wijsenbeek, Marlies S., Mirjam Kool, and Vincent Cottin. "Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end." European Respiratory Journal 52.6 (2018): 1802111. Web. 17 Aug. 2022.
  6. Wung, Peter

    1. Raghu, Ganesh et al "SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)." European Respiratory Journal 52.6 (2018): 1801130. Web. 17 Aug. 2022.

X

  1. Xin, Henan

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.

Y

  1. Yan, Jiaoxia

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  2. Yancey, Steve

    1. Shrimanker, Rahul et al "Exacerbations of severe asthma in patients treated with mepolizumab." European Respiratory Journal 52.6 (2018): 1801127. Web. 17 Aug. 2022.

Z

  1. Zenner, Dominik

    1. Collin, Simon M. et al "Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes." European Respiratory Journal 52.6 (2018): 1801449. Web. 17 Aug. 2022.
  2. Zhang, Haoran

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  3. Zhang, Zongde

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
  4. Zhou, Xinhua

    1. Gao, Lei et al "Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study." European Respiratory Journal 52.6 (2018): 1801470. Web. 17 Aug. 2022.
Back to top
PreviousNext
European Respiratory Journal: 52 (6)
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorials
  • ERS Official Documents
    • ERS statement
  • Original Articles
    • Lung cancer
    • Asthma
    • Cystic fibrosis
    • Interstitial lung diseases
    • Tuberculosis
    • Allergy and basic science
  • Reviews
  • Series
  • Agora
    • Research letters
    • Correspondence
  • Author Correction
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • Pulsus paradoxus
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  • Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society